Universe Pharmaceuticals Inc. EBITDA for the year ending September 30, 2024: USD -7.36 M

Universe Pharmaceuticals Inc. EBITDA is USD -7.36 M for the year ending September 30, 2024, a 128.82% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Universe Pharmaceuticals Inc. EBITDA for the year ending September 30, 2023 was USD -3.22 M, a -49.75% change year over year.
  • Universe Pharmaceuticals Inc. EBITDA for the year ending September 30, 2022 was USD -6.40 M, a -145.07% change year over year.
  • Universe Pharmaceuticals Inc. EBITDA for the year ending September 30, 2021 was USD 14.20 M, a 33.77% change year over year.
  • Universe Pharmaceuticals Inc. EBITDA for the year ending September 30, 2020 was USD 10.61 M, a 4.31% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)